本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

10.62
-0.8500-7.41%
盘后10.830.2100+1.98%19:30 EDT
成交量:239.18万
成交额:2,573.91万
市值:23.25亿
市盈率:-7.51
高:11.43
开:11.43
低:10.54
收:11.47
52周最高:16.44
52周最低:6.23
股本:2.19亿
流通股本:1.85亿
量比:1.08
换手率:1.29%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
净资产收益率:-72.99%
总资产收益率:-34.95%
市净率:4.47
市盈率(LYR):-7.48

数据加载中...

2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities